Search
Now showing items 1-1 of 1
An anti-SARS-CoV-2 metabolite is reduced in diabetes
(Nature Research, 2022-05-09)
A glucose-like metabolite, which is reduced in the serum of diabetic patients, inhibits the entry of SARS-CoV-2 into key cellular targets. The work led by Cheng and colleagues provides a molecular ...